Medicine Supply Notification: Mesalazine (Asacol® ) 400mg and 800mg MR gastro-resistant tablets

Department of Health and Social Care (DHSC) has issued a Medicine Supply Notification (MSN) for Mesalazine (Asacol®) 400mg and 800mg MR gastro-resistant tablets.

MSN/2022/007

Tier 2 – medium impact

Date of issue: 10/02/2022

  • Asacol® 400mg and 800mg MR gastro-resistant tablets are out of stock until mid-March 2022.
  • Octasa® MR 400mg and 800mg tablets remain available and can support a full uplift in demand during this period.
  • Other mesalazine tablet preparations with different release characteristics remain available, should Octasa® MR tablets not be considered appropriate.

The DHSC Medicine Supply Team provide a monthly update on potential supply issues affecting both primary and secondary care. This update is uploaded on the Specialist Pharmacy Services (SPS) website. To register, you will need  an NHS email address. Once set up and logged in, you will be able to access it online.

New shortages not listed on the SPS website, can be reported using our shortage reporting tool.